COMMONWEALTH CANCER CONSORTIUM INC
AI Summary
COMMONWEALTH CANCER CONSORTIUM INC, operating as Break Through Cancer, is a cancer research nonprofit dedicated to supporting translational research for some of the most difficult-to-treat cancers through multi-institutional collaboration among scientists, engineers, and clinical researchers. In its 2024 filing year, it reported $13.4M in revenue against a $28.7M operating budget, and its listed top funders include COMMONWEALTH FOUNDATION FOR CANCER RESEARCH, which provided $83.4M in 2024, MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION, which provided $5M in 2022, and ALK POSITIVE INC, which provided $500K in 2024.
Mission Statement


There’s more to this organization
Create a free account to go deeper. No payment required.
- 8 funders
- 27 board & team members
- 5 historic 990s & financials
- 6-year operating budget trend
Is your org on Google Workspace or Microsoft 365? Sign up in seconds. Already have an account? Log in
